Zydus to attend 360 ONE Capital conference on May 27

0 min read Updated on 21 May 2026, 11:55 AM

Reviewed by

Shriram SScanX News Team

AI Summary

Zydus Lifesciences Limited will participate in the 360 ONE Capital (B&K) 16th Annual Investor Conference - TRINITY INDIA 2026 on May 27, 2026. The company disclosed this via a regulatory filing on May 21, 2026.

*this image is generated using AI for illustrative purposes only.

Zydus Lifesciences Limited has announced that it will participate in the upcoming 360 ONE Capital (B&K) 16th Annual Investor Conference. The event, known as TRINITY INDIA 2026, is scheduled to be held on May 27, 2026.

The company confirmed its attendance through a regulatory filing submitted to the stock exchanges. The disclosure was made to inform investors and the exchange members about the management's engagement at the conference.

The following table outlines the key details of the event:

Event Detail	Information
Conference Name	360 ONE Capital (B&K) 16th Annual Investor Conference - TRINITY INDIA 2026
Date	May 27, 2026
Regulation	Regulation 30

The filing was signed by Dhaval N. Soni, Company Secretary and Compliance Officer of Zydus Lifesciences Limited. The update is intended to keep the investing public informed about the company's investor relations activities.

Historical Stock Returns for Zydus Life Science

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+3.27%	+6.05%	+15.38%	+16.08%	+18.76%	+72.71%

What strategic updates or pipeline milestones is Zydus Lifesciences likely to highlight to institutional investors at TRINITY INDIA 2026?

How might Zydus Lifesciences' participation in high-profile investor conferences impact its institutional ownership and stock liquidity in the near term?

What key financial guidance or business outlook could Zydus management share at the conference that might influence analyst ratings or price targets?

Read Next Article

Zydus completes Rs 128.83 m investment in Torrent Urja 25

1 min read Updated on 21 May 2026, 07:02 AM

Reviewed by

Jubin VScanX News Team

Add as a preferred
source on Google

AI Summary

Zydus Lifesciences Limited and its subsidiaries have completed the subscription of equity shares in Torrent Urja 25 Private Limited by investing the remaining Rs. 90.18 million on May 19, 2026. This final tranche, covering Tranches 2, 3, and 4, involved 90,17,848 equity shares and brought the total investment to Rs. 128.83 million for 1,28,82,640 shares. The transaction, executed under Share Subscription and Shareholders’ Agreements, aligns with the company's ESG commitments and carbon neutrality goals.

*this image is generated using AI for illustrative purposes only.

Zydus Lifesciences Limited and its subsidiaries have successfully completed the subscription of equity shares in Torrent Urja 25 Private Limited. The company invested the remaining amount of Rs. 90.18 million on May 19, 2026, for the subscription of 90,17,848 equity shares under Tranche 2, 3, and 4. This investment represents 22.06% of the paid-up share capital of Torrent Urja 25.

The transaction was executed pursuant to the Share Subscription and Shareholders’ Agreements (SSSAs) previously entered into by the parties. Following this investment, the entire transaction of subscription of shares in Torrent Urja 25 has been consummated as of May 19, 2026. The investment underscores the company’s commitment to environmental, social, and governance (ESG) principles and aligns with its strategic objective of achieving carbon neutrality.

Investment Details

The investment was carried out in multiple tranches as per the terms of the SSSAs. The following table outlines the investment made across the different tranches:

Tranche	Investment Amount (Rs.)	Equity Shares Subscribed	Stake in Paid-up Capital
Tranche 1	38.65 million	38,64,792	22.06%
Tranche 2, 3, and 4	90.18 million	90,17,848	22.06%

Background

Earlier intimations dated May 28, 2025, and June 27, 2025, had detailed the structure of this investment. The first tranche saw an aggregate investment of Rs. 38.65 million for 38,64,792 equity shares. The recent completion of the subsequent tranches brings the total investment to Rs. 128.83 million for a total of 1,28,82,640 equity shares.

Historical Stock Returns for Zydus Life Science

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+3.27%	+6.05%	+15.38%	+16.08%	+18.76%	+72.71%

How will Zydus Lifesciences' 22.06% stake in Torrent Urja 25 translate into measurable progress toward its carbon neutrality targets, and what timeline has the company set for achieving this goal?

Could Zydus Lifesciences look to increase its stake in Torrent Urja 25 beyond 22.06%, or are there plans to make similar renewable energy investments with other entities to further its ESG commitments?

What impact will the energy generated through Torrent Urja 25 have on Zydus Lifesciences' operational costs, and how might this affect its profit margins over the next 3-5 years?